aspsirna0366 details

Purple = Wild vs mutant target sequence along with mutation information
Brown= Wild vs ASP-siRNA description along with positional differnece between two
Light pink= ASP siRNA efficacy for mutant vs wild allele
Green= Wild siRNA efficacy for Wild vs Mutant allele
siRNA Id:aspsirna0366
siRNA Name: Si19
Gene:Collagen, type III, alpha 1 (COL3A1)
Disease:Vascular Ehlers-Danlos Syndrome (vEDs)
Wild allele/target (5'->3'): GACCUCCAGGUAUCAAAGG
Mutant allele/target (5'->3'):GACCUCCAGGUAUCAAAGU
Target Mutation: c.764G>T,p.Gly255Val
Wild siRNA (As strand):CUGGAGGUCCAUAGUUUCC
ASP-siRNA (As strand):CUGGAGGUCCAUAGUUUCA
Mismatch position in siRNA: A1C
Mutant allele (5'->3'): GACCUCCAGGUAUCAAAGU
ASP-siRNA (As strand):CUGGAGGUCCAUAGUUUCA
ASP-siRNA efficacy for mutant allele:86
Wild allele (5'->3'): GACCUCCAGGUAUCAAAGG
ASP-siRNA (As strand):CUGGAGGUCCAUAGUUUCA
ASP-siRNA efficacy for wild allele:62
Percentage discrimination for ASP-siRNA:24
Wild allele (5'->3'): GACCUCCAGGUAUCAAAGG
Wild siRNA (As strand):CUGGAGGUCCAUAGUUUCC
Wild sirna efficacy for wild allele:47
Wild allele (5'->3'): GACCUCCAGGUAUCAAAGG
ASP-siRNA (As strand):CUGGAGGUCCAUAGUUUCA
Wild sirna efficacy for mutant allele:20
Percentage discrimination for wild siRNA:27
Concentration:100nM
Orientation:Sense
Mismatch in:siRNA
UniProt ID: P02461
Target sequence: CCUGGACCUCCAGGUAUCAAAGGUCCAGCUGGGAUACCUGGAU
Genbank Accesion: NM_000090.3
Cell-line: Fibroblast
Experimental technique used: Dual luciferase reporter assay
Transfection method: Dharmafect 1
siRNA expression method: Invitrogen
Post-transfection duration: 48 hours
OMID ID: 130050
KEGG disease ID:H00802
Reference:22038052

.
.
.
.
.
.
.
.
.
.
.

.

.

.